Patents by Inventor Andre P. Boulet

Andre P. Boulet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11723938
    Abstract: Use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of inflammatory bowel disease, and method for the treatment thereof. The inflammatory bowel disease may comprise several diseases associated with inflammation of the small intestine, large intestine (colon), rectum or anus (anal sphincter), and may be particularly selected from ulcerative colitis and Crohn's disease.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: August 15, 2023
    Assignee: Groupe Santé Devonian Inc.
    Inventors: André P. Boulet, Theophilus J. Gana, Nathalie Boucher
  • Patent number: 11033592
    Abstract: There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of cardiovascular diseases, and method for the treatment thereof. The cardiovascular diseases (CVD) may comprise several diseases associated with inflammation of the heart or arteries and include coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack), atherosclerosis, stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: June 15, 2021
    Assignee: GROUPE SANTÉ DEVONIAN INC.
    Inventors: André P. Boulet, Theophilus J. Gana, Nathalie Boucher
  • Publication number: 20210128659
    Abstract: Use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of inflammatory bowel disease, and method for the treatment thereof. The inflammatory bowel disease may comprise several diseases associated with inflammation of the small intestine, large intestine (colon), rectum or anus (anal sphincter), and may be particularly selected from ulcerative colitis and Crohn's disease.
    Type: Application
    Filed: August 20, 2020
    Publication date: May 6, 2021
    Inventors: André P. Boulet, Theophilus J. Gana, Nathalie Boucher
  • Patent number: 10786538
    Abstract: There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of inflammatory bowel disease, and method for the treatment thereof. The inflammatory bowel disease may comprise several diseases associated with inflammation of the small intestine, large intestine (colon), rectum or anus (anal sphincter), and may be particularly selected from ulcerative colitis and Crohn's disease.
    Type: Grant
    Filed: November 2, 2016
    Date of Patent: September 29, 2020
    Assignee: Groupe Santé Devonian Inc.
    Inventors: André P. Boulet, Theophilus J. Gana, Nathalie Boucher
  • Patent number: 10653615
    Abstract: The invention relates to cosmetic and topical compositions containing an effective amount of a photosynthetic cell extract comprising a functional thylakoid system. The cosmetic compositions have anti-wrinkle and anti-aging effects on a user's skin. In addition, the photosynthetic cell extract protects skin against ultraviolet A (UVA) and ultraviolet (UVB) damage.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: May 19, 2020
    Inventors: Andre P. Boulet, Paul Maes
  • Publication number: 20190314433
    Abstract: There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of cardiovascular diseases, and method for the treatment thereof. The cardiovascular diseases (CVD) may comprise several diseases associated with inflammation of the heart or arteries and include coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack), atherosclerosis, stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis.
    Type: Application
    Filed: November 3, 2017
    Publication date: October 17, 2019
    Inventors: André P. Boulet, Theophilus J. Gana, Nathalie Boucher
  • Publication number: 20180362921
    Abstract: There is provided an improved extraction process for obtaining integral & active thylakoid membranes that have longer shelf-life at room temperature. Particularly, the extract is lyophilized in a solution of PVP and remains stable with at least 80% of its original activity for at least 7 days at room temperature, respectively.
    Type: Application
    Filed: December 13, 2016
    Publication date: December 20, 2018
    Inventors: André P. BOULET, Nathalie BOUCHER
  • Publication number: 20180325802
    Abstract: The invention relates to cosmetic and topical compositions containing an effective amount of a photosynthetic cell extract comprising a functional thylakoid system. The cosmetic compositions have anti-wrinkle and anti-aging effects on a user's skin. In addition, the photosynthetic cell extract protects skin against ultraviolet A (UVA) and ultraviolet (UVB) damage.
    Type: Application
    Filed: July 9, 2018
    Publication date: November 15, 2018
    Inventors: Andre P. BOULET, Paul MAES
  • Publication number: 20180311293
    Abstract: There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of inflammatory bowel disease, and method for the treatment thereof. The inflammatory bowel disease may comprise several diseases associated with inflammation of the small intestine, large intestine (colon), rectum or anus (anal sphincter), and may be particularly selected from ulcerative colitis and Crohn's disease.
    Type: Application
    Filed: November 2, 2016
    Publication date: November 1, 2018
    Applicant: Groupe Santé Devonian Inc.
    Inventors: André P. BOULET, Theophilus J. GANA, Nathalie BOUCHER
  • Patent number: 10045934
    Abstract: The invention relates to cosmetic and topical compositions containing an effective amount of a photosynthetic cell extract comprising a functional thylakoid system. The cosmetic compositions have anti-wrinkle and anti-aging effects on a user's skin. In addition, the photosynthetic cell extract protects skin against ultraviolet A (UVA) and ultraviolet (UVB) damage.
    Type: Grant
    Filed: April 12, 2011
    Date of Patent: August 14, 2018
    Assignee: Groupe Sante Devonian
    Inventors: Andre P. Boulet, Paul Maes
  • Publication number: 20130309181
    Abstract: The invention relates to cosmetic and topical compositions containing an effective amount of a photosynthetic cell extract comprising a functional thylakoid system. The cosmetic compositions have anti-wrinkle and anti-aging effects on a user's skin. In addition, the photosynthetic cell extract protects skin against ultraviolet A (UVA) and ultraviolet (UVB) damage.
    Type: Application
    Filed: April 12, 2011
    Publication date: November 21, 2013
    Inventors: Andre P. Boulet, Paul Maes